Biofrontera Stock Probability of Future Stock Price Finishing Over 27.01
| BFRI Stock | USD 0.90 0.09 9.09% |
Biofrontera |
Biofrontera Target Price Odds to finish over 27.01
The tendency of Biofrontera Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 27.01 or more in 90 days |
| 0.90 | 90 days | 27.01 | close to zero percent |
Based on a normal probability distribution, the odds of Biofrontera to move over $ 27.01 or more in 90 days from now is close to zero percent (This Biofrontera probability density function shows the probability of Biofrontera Stock to fall within a particular range of prices over 90 days) . Probability of Biofrontera price to stay between its current price of $ 0.90 and $ 27.01 at the end of the 90-day period is about 71.87 .
Given the investment horizon of 90 days Biofrontera has a beta of -2.01 suggesting as returns on its benchmark rise, returns on holding Biofrontera are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Biofrontera is expected to outperform its benchmark. Additionally Biofrontera has an alpha of 0.4076, implying that it can generate a 0.41 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Biofrontera Price Density |
| Price |
Predictive Modules for Biofrontera
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biofrontera. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biofrontera Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biofrontera is not an exception. The market had few large corrections towards the Biofrontera's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biofrontera, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biofrontera within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.41 | |
β | Beta against Dow Jones | -2.01 | |
σ | Overall volatility | 0.19 | |
Ir | Information ratio | 0 |
Biofrontera Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biofrontera for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biofrontera can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biofrontera generated a negative expected return over the last 90 days | |
| Biofrontera has high historical volatility and very poor performance | |
| Biofrontera has some characteristics of a very speculative penny stock | |
| Biofrontera has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 34.07 M. Net Loss for the year was (20.13 M) with profit before overhead, payroll, taxes, and interest of 13.49 M. | |
| Biofrontera currently holds about 31.91 M in cash with (24.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biofrontera has a frail financial position based on the latest SEC disclosures | |
| Roughly 32.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Hermann Luebbert of 190840 shares of Biofrontera subject to Rule 16b-3 |
Biofrontera Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biofrontera Stock often depends not only on the future outlook of the current and potential Biofrontera's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biofrontera's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 M | |
| Cash And Short Term Investments | 1.4 M |
Biofrontera Technical Analysis
Biofrontera's future price can be derived by breaking down and analyzing its technical indicators over time. Biofrontera Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biofrontera. In general, you should focus on analyzing Biofrontera Stock price patterns and their correlations with different microeconomic environments and drivers.
Biofrontera Predictive Forecast Models
Biofrontera's time-series forecasting models is one of many Biofrontera's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biofrontera's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biofrontera
Checking the ongoing alerts about Biofrontera for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biofrontera help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biofrontera generated a negative expected return over the last 90 days | |
| Biofrontera has high historical volatility and very poor performance | |
| Biofrontera has some characteristics of a very speculative penny stock | |
| Biofrontera has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 34.07 M. Net Loss for the year was (20.13 M) with profit before overhead, payroll, taxes, and interest of 13.49 M. | |
| Biofrontera currently holds about 31.91 M in cash with (24.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Biofrontera has a frail financial position based on the latest SEC disclosures | |
| Roughly 32.0% of the company shares are held by company insiders | |
| Latest headline from MacroaxisInsider: Acquisition by Hermann Luebbert of 190840 shares of Biofrontera subject to Rule 16b-3 |
Check out Biofrontera Backtesting, Biofrontera Valuation, Biofrontera Correlation, Biofrontera Hype Analysis, Biofrontera Volatility, Biofrontera History as well as Biofrontera Performance. For more detail on how to invest in Biofrontera Stock please use our How to Invest in Biofrontera guide.You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 1.16 | Revenue Per Share 11.573 | Quarterly Revenue Growth 0.34 | Return On Assets (0.40) | Return On Equity (1.49) |
The market value of Biofrontera is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera's value that differs from its market value or its book value, called intrinsic value, which is Biofrontera's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera's market value can be influenced by many factors that don't directly affect Biofrontera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.